Stocksigma LogoStocksigma Logo

Syngene Reports Q2 FY27 Financial Results with Strong Sequential Performance

Syngene International posted Q2 FY27 revenue from operations of Rs 833 Cr, up 13% QoQ but down 9% YoY due to lower Zoetis revenues and forex hedge losses

Syngene Reports Q2 FY27 Financial Results with Strong Sequential Performance

Syngene International Ltd 路 Press Release 路 28 Oct 2026, 2:10 am

Syngene Reports Q2 FY27 Financial Results with Strong Sequential Performance Syngene International posted Q2 FY27 revenue from operations of Rs 833 Cr, up 13% QoQ but down 9% YoY due to lower Zoetis revenues and forex hedge losses. Operating EBITDA rose to Rs 147 Cr with margins expanding 600 bps QoQ to 18%, while PAT reached Rs 32 Cr versus a loss of Rs 9 Cr in Q1 FY27. Key operational milestones included signing the first manufacturing agreement for the US Bayview biologics facility and securing additional contracts. CFO Deepak Jain resigned for personal reasons.

Original exchange filing (PDF)

More announcements from Syngene International Ltd

All Syngene International Ltd announcements